RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Christopher Navara to Tubulin

This is a "connection" page, showing publications Christopher Navara has written about Tubulin.
Connection Strength

0.184
  1. Uckun FM, Mao C, Jan ST, Huang H, Vassilev AO, Navara CS, Narla RK. Spongistatins as tubulin targeting agents. Curr Pharm Des. 2001 Sep; 7(13):1291-6.
    View in: PubMed
    Score: 0.050
  2. Jan ST, Mao C, Vassilev AO, Navara CS, Uckun FM. COBRA-1, a rationally-designed epoxy-THF containing compound with potent tubulin depolymerizing activity as a novel anticancer agent. Bioorg Med Chem Lett. 2000 Jun 05; 10(11):1193-7.
    View in: PubMed
    Score: 0.046
  3. Uckun FM, Mao C, Vassilev AO, Navara CS, Narla RK, Jan ST. A rationally designed anticancer drug targeting a unique binding cavity of tubulin. Bioorg Med Chem Lett. 2000 May 15; 10(10):1015-8.
    View in: PubMed
    Score: 0.045
  4. Simerly C, Zoran SS, Payne C, Dominko T, Sutovsky P, Navara CS, Salisbury JL, Schatten G. Biparental inheritance of gamma-tubulin during human fertilization: molecular reconstitution of functional zygotic centrosomes in inseminated human oocytes and in cell-free extracts nucleated by human sperm. Mol Biol Cell. 1999 Sep; 10(9):2955-69.
    View in: PubMed
    Score: 0.043
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support